Press release
Gene-to-Patient Market Growing at 12.5 Percent CAGR Driven by Rising Demand for Personalized Genetic Therapies Across Multiple Disease Segments
Gene-to-Patient Market
According to the latest research by InsightAce Analytic, the Gene-to-Patient Market is valued at US$ 134.6 Bn in 2023, and it is expected to reach US$ 341.4 Bn by 2031, with a CAGR of 12.5% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2905
The "gene-to-patient" model encompasses the development and delivery of personalized genetic therapies, enabling highly targeted medical interventions tailored to individual patient profiles. This model is gaining significant traction globally, propelled by the rising incidence of chronic diseases, increased investment in research and development, and the growing integration of gene therapy into clinical practice. Furthermore, strategic collaborations among international organizations are facilitating the exploration of more effective and scalable applications of gene-based treatments.
Despite its promising outlook, the gene-to-patient industry faces several challenges. Regulatory complexities associated with the approval, standardization, and clinical implementation of genetic therapies remain a substantial barrier. In addition, market expansion in developing economies is hindered by ongoing concerns regarding healthcare affordability and limited access to advanced medical technologies. Nevertheless, the sector holds considerable growth potential as stakeholders navigate regulatory frameworks and introduce innovative, cost-effective therapeutic solutions. These dynamics are expected to drive continued growth in the global gene-to-patient market over the coming years.
List of Prominent Players in the Gene-to-Patient Market:
• Illumina
• Thermo Fisher Scientific
• Roche Diagnostics
• Qiagen
• BioRad Laboratories
• Abbott Laboratories
• PerkinElmer
• Invitae
• Myriad Genetics
• Merck
• Guardant Health
• Foundation Medicine
• Genomic Health
• Agilent Technologies
• Laboratory Corporation of America (LabCorp)
• Exact Sciences
• Genscript Biotech Corporation
• CRISPR Therapeutics AG
• Editas Medicine
• Intellia Therapeutics Inc.
• Beam Therapeutics Inc.
• Caribou Biosciences Inc.
• Lonza Group Ltd.
• Other Market Players
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Market Dynamics
Drivers:
The gene-to-patient market is witnessing robust growth, primarily driven by the increasing incidence of genetic disorders and the rising demand for effective therapeutic alternatives. The market is further propelled by the growing adoption of personalized medicine, as healthcare providers and patients increasingly prioritize treatment approaches tailored to individual genetic profiles. Continuous advancements in genetic engineering and biotechnology have significantly improved the precision and efficacy of gene therapies, facilitating the accurate identification of genetic anomalies and enabling new treatment breakthroughs for complex genetic diseases. These technological innovations are expected to sustain and accelerate the expansion of the gene-to-patient market.
Challenges:
Despite its growth potential, the gene-to-patient market faces several challenges. Limited public awareness regarding the availability and benefits of gene therapy continues to impede patient acceptance and adoption. Additionally, the high costs associated with gene therapy procedures present a major obstacle to accessibility, particularly for underserved populations. Furthermore, the market is constrained by varying and often rigorous regulatory frameworks across global regions, which complicate the approval processes and may delay the commercialization of new therapies.
Regional Trends:
North America is anticipated to maintain a leading position in the global gene-to-patient market, underpinned by strong governmental and private sector investment in gene therapy research and development. The presence of a favorable regulatory landscape, well-established healthcare infrastructure, and active public funding for clinical trials further supports regional market growth. In Europe, the market is also expanding steadily, driven by improvements in healthcare infrastructure, rising urbanization, and growing consumer spending capacity. These factors collectively contribute to the region's increasing adoption of gene-based medical solutions and the broader growth of the gene-to-patient sector.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2905
Recent Developments:
• In March 2024, Merck, a frontrunner in the scientific and technological industries, introduced the world to the first comprehensive, laboratory-validated genetic stability test. Accelerating biosafety assessment and the transition into commercial production, the Aptegra CHO genetic stability assay utilizes whole genome sequencing and bioinformatics.
Segmentation of Gene-to-Patient Market-
By Type-
• Gene Therapy
• Gene Editing
• Gene Silencing
By Application-
• Cancer Treatment
• Genetic Disorders
• Cardiovascular Diseases
• Rare Diseases
• Infectious Diseases
By End-user-
• Hospitals
• Research Institutes
• Biopharmaceutical Companies
• Diagnostic Laboratories
By Technology-
• CRISPR
• Viral Vector Technology
• Non-Viral Delivery Technology
• Antisense Oligonucleotide Technology
By Distribution Channel-
• Direct Sales
• Online Sales
• Third-party Distributors
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/gene-to-patient-market/2905
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene-to-Patient Market Growing at 12.5 Percent CAGR Driven by Rising Demand for Personalized Genetic Therapies Across Multiple Disease Segments here
News-ID: 4051128 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Microdermabrasion Devices Market Study Analysis with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Microdermabrasion Devices Market Size, Share & Trends Analysis Report By Type (Diamond, Crystal Microdermabrasion Devices), Application (Acne And Scars, Photo Damage, Anti-Aging, Hyperpigmentation, Stretch Marks) And End User (Hospitals And Clinics And Home Use)- Market Outlook And Industry Analysis 2031"
The Global Microdermabrasion Devices Market is estimated to reach over USD 1149.25 million by 2031, exhibiting…
mHealth Solutions Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global mHealth Solutions Market Size, Share & Trends Analysis Report By Product Type (Patient Management & Monitoring Apps, Medical Reference Apps, Women's health apps, Diabetes Management Apps, Medication management apps), Services (Remote monitoring services, Diagnosis & Consultation services, Treatment services, Healthcare system strengthening services, Fitness & wellness services, Prevention services), End-users (healthcare providers, healthcare payers, patients)-…
Medical X-Ray Detectors Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Medical X-Ray Detectors Market Size, Share & Trends Analysis Report By Product (Flat Panel Detectors, Medical X-Ray Detectors Market, And Computed Radiography Detectors. Flat Panel Detectors), Application (Static Imaging And Dynamic Imaging), Modalities (Portable Detectors And Fixed Detectors), Module Type (New Digital X-Ray Systems And Retrofit X-Ray Systems), And End-User (Hospitals, Clinics, And Diagnostic Centers)-…
Medical Device Regulatory Affairs Market Future Trends and Scope Analysis Report
"Medical Device Regulatory Affairs Market" in terms of revenue was estimated to be worth $ 6.7 billion in 2024 and is poised to reach $ 18.3 billion by 2034, growing at a CAGR of 10.8% from 2025 to 2034 according to a new report by InsightAce Analytic.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1913
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global medical device regulatory…
More Releases for Gene
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with…
Gene Editing Market : A Market Study On Gene Editing And Cancer Therapy Techniqu …
Global Gene Editing Market
Precision Business Insights (PBI) in its report titled “Global Gene Editing Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
Gene editing or Genome editing is…
Direct-to-consumer Genetic Testing Market: Top Players - Gene By Gene, MyHeritag …
Latest industry research report on: Global and United States Direct-to-consumer Genetic Testing Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
This report studies the Direct-to-consumer Genetic Testing market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Direct-to-consumer Genetic Testing market by product…
